X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
27
PharmaCompass offers a list of Ibuprofen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibuprofen manufacturer or Ibuprofen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibuprofen manufacturer or Ibuprofen supplier.
PharmaCompass also assists you with knowing the Ibuprofen API Price utilized in the formulation of products. Ibuprofen API Price is not always fixed or binding as the Ibuprofen Price is obtained through a variety of data sources. The Ibuprofen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AM20060782 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AM20060782, including repackagers and relabelers. The FDA regulates AM20060782 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AM20060782 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AM20060782 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AM20060782 supplier is an individual or a company that provides AM20060782 active pharmaceutical ingredient (API) or AM20060782 finished formulations upon request. The AM20060782 suppliers may include AM20060782 API manufacturers, exporters, distributors and traders.
click here to find a list of AM20060782 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AM20060782 DMF (Drug Master File) is a document detailing the whole manufacturing process of AM20060782 active pharmaceutical ingredient (API) in detail. Different forms of AM20060782 DMFs exist exist since differing nations have different regulations, such as AM20060782 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AM20060782 DMF submitted to regulatory agencies in the US is known as a USDMF. AM20060782 USDMF includes data on AM20060782's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AM20060782 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AM20060782 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The AM20060782 Drug Master File in Japan (AM20060782 JDMF) empowers AM20060782 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the AM20060782 JDMF during the approval evaluation for pharmaceutical products. At the time of AM20060782 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of AM20060782 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a AM20060782 Drug Master File in Korea (AM20060782 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AM20060782. The MFDS reviews the AM20060782 KDMF as part of the drug registration process and uses the information provided in the AM20060782 KDMF to evaluate the safety and efficacy of the drug.
After submitting a AM20060782 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AM20060782 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of AM20060782 suppliers with KDMF on PharmaCompass.
A AM20060782 CEP of the European Pharmacopoeia monograph is often referred to as a AM20060782 Certificate of Suitability (COS). The purpose of a AM20060782 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AM20060782 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AM20060782 to their clients by showing that a AM20060782 CEP has been issued for it. The manufacturer submits a AM20060782 CEP (COS) as part of the market authorization procedure, and it takes on the role of a AM20060782 CEP holder for the record. Additionally, the data presented in the AM20060782 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AM20060782 DMF.
A AM20060782 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AM20060782 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of AM20060782 suppliers with CEP (COS) on PharmaCompass.
A AM20060782 written confirmation (AM20060782 WC) is an official document issued by a regulatory agency to a AM20060782 manufacturer, verifying that the manufacturing facility of a AM20060782 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AM20060782 APIs or AM20060782 finished pharmaceutical products to another nation, regulatory agencies frequently require a AM20060782 WC (written confirmation) as part of the regulatory process.
click here to find a list of AM20060782 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AM20060782 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AM20060782 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AM20060782 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AM20060782 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AM20060782 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AM20060782 suppliers with NDC on PharmaCompass.
AM20060782 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AM20060782 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AM20060782 GMP manufacturer or AM20060782 GMP API supplier for your needs.
A AM20060782 CoA (Certificate of Analysis) is a formal document that attests to AM20060782's compliance with AM20060782 specifications and serves as a tool for batch-level quality control.
AM20060782 CoA mostly includes findings from lab analyses of a specific batch. For each AM20060782 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AM20060782 may be tested according to a variety of international standards, such as European Pharmacopoeia (AM20060782 EP), AM20060782 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AM20060782 USP).
Market Place
